Chemoprevention of colorectal cancer in inflammatory bowel disease.
Butterworth
J R
JR
Department of Gastroenterology, Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, Shropshire, United Kingdom. j.r.butterworth@btinternet.com
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D015179:Colorectal Neoplasms / Q000453:epidemiology* / Q000517:prevention & control*; D015897:Comorbidity; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000453:epidemiology*; D019804:Mesalamine / Q000008:administration & dosage*; D045726:Metalloproteases / Q000187:drug effects / Q000235:genetics; D016328:NF-kappa B / Q000187:drug effects; D047495:PPAR gamma / Q000187:drug effects; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016328:NF-kappa B; D047495:PPAR gamma; D019804:Mesalamine; D045726:Metalloproteases